Biomedical laboratories
New research on lung cancer has shed light on the critical importance of postoperative symptom cluster assessment in improving functional recovery and long-term outcomes in patients. According to a study conducted by researchers from Zhongshan Hospital Xiamen University, patients who underwent surgical treatment for lung cancer were categorized into two
Cancer
Research conducted by Shandong University in Jinan, People's Republic of China, explored the interrelationships between parental burnout, sibling relationship quality, and quality of life in children with cancer. The study used a cross-sectional design and enrolled 218 children with cancer and their parents in three tertiary hospitals in
Cancer research
A new study published in the Dental Journal has shed light on the potential treatment of oral mucositis (OM) in patients undergoing radiotherapy for head and neck cancer. According to the research, a combination of pharmacological therapy and low-level laser therapy (LLLT) was effective in maintaining and improving the condition
Cancer
Researchers at the First Affiliated Hospital of Air Force Medical University in Shaanxi, People's Republic of China, have developed a new scoring system to help predict the prognosis of gastric cancer patients. The Immune-Inflammatory-Nutritional-Tumor Marker (IINTM) score combines several indices, including the Prognostic Nutritional Index (PNI) and Systemic
Cancer
Researchers at the National Cancer Centre Singapore have conducted a qualitative study to explore patients' experiences with routine integration of patient-reported outcome measures (PROMs) in oncology settings. The study aimed to understand the challenges and strategies for implementing PROMs in a healthcare setting. The research findings suggest that successful
Cancer research
A new study conducted by researchers from Fourth Hospital of Hebei Medical University has evaluated the cost-effectiveness of adoptive cellular immunotherapy (ACI) combined with chemotherapy versus chemotherapy alone in Chinese patients with metastatic colorectal cancer (mCRC). The study, published in Frontiers in Oncology, found that ACI combined with chemotherapy provided
Cancer
A recent study published in Oncology and Therapy has revealed that patients with bone metastases often feel adequately informed about their condition, but may still require more detailed guidance on specific treatments and dental evaluations. The research, conducted by IRCCS Sacro Cuore Don Calabria Hospital, surveyed 351 patients with bone
Cancer
A.C. Camargo Cancer Center, a leading oncology treatment center in Sao Paulo, Brazil, has deployed more than 2,000 state-of-the-art video surveillance cameras throughout the Center's corridors, complex care units, and parking lots, enhancing patient and employee safety while improving quality of service. The partnership with Axis
Cancer research
Research conducted at Shandong University in the People's Republic of China has led to the development of a predictive model capable of identifying patients with metastatic colorectal cancer (mCRC) who may benefit from primary tumor resection (PTR). The study utilized clinical data from the Surveillance, Epidemiology, and End
Cancer research
Investigators at Sun Yat-Sen University in Guangzhou, People's Republic of China, have found that Continuous Glucose Monitoring (CGM) significantly improves outcomes in type 2 diabetes patients undergoing colorectal cancer surgery. The study, published in Frontiers in Medicine, demonstrated that CGM reduces glycemic variability, surgical complications, and promotes wound
Cancer research
Researchers from Peking University have revealed significant disparities in lung cancer care under tiered social health insurance (SHI) in China. A population-based study of 319,677 patients diagnosed with lung cancer between 2017 and 2021 in Shandong, China, found that those under the Urban Employee Basic Medical Insurance (UEBMI) scheme
Cancer
Researchers from The University of Texas MD Anderson Cancer Center have reported encouraging results from a Phase I/II study on the antibody-drug conjugate pivekimab sunirine (PVEK) in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and aggressive blood cancer. The study, led by Naveen Pemmaraju, M.D., and
